Pharmacology and the Nursing Process by Linda Lane Lilley: Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the Pharmacology and the Nursing Process by Linda Lane Lilley Exam. Enhance your skills with multiple choice questions and detailed explanations. Get exam-ready!

Practice this question and more.

What might result from concurrent use of aminocaproic acid and estrogens?

Decreased coagulation
Increased coagulation
Reduced blood pressure
Impaired wound healing

The correct answer is: Increased coagulation

Concurrent use of aminocaproic acid and estrogens can result in increased coagulation. Aminocaproic acid is an antifibrinolytic medication that prevents the breakdown of blood clots, while estrogens can increase the production of clotting factors in the blood. Therefore, using these two medications together can lead to an excessive and potentially dangerous increase in blood clotting. None of the other options, such as decreased coagulation, reduced blood pressure, or impaired wound healing, are known effects of using these medications together.